May 2, 2009

Guess who is OWNS Gilead who makes Tamiflu? Donald Rumsfeld!



Rumsfeld's growing stake in Tamiflu
Defense Secretary, ex-chairman of flu treatment rights holder, sees portfolio value growing.
October 31, 2005: 10:55 AM EST
By Nelson D. Schwartz, Fortune senior writer

NEW YORK (Fortune) - The prospect of a bird flu outbreak may be panicking people around the globe, but it's proving to be very good news for Defense Secretary Donald Rumsfeld and other politically connected investors in Gilead Sciences, the California biotech company that owns the rights to Tamiflu, the influenza remedy that's now the most-sought after drug in the world.

Rumsfeld served as Gilead (Research)'s chairman from 1997 until he joined the Bush administration in 2001, and he still holds a Gilead stake valued at between $5 million and $25 million, according to federal financial disclosures filed by Rumsfeld.

The forms don't reveal the exact number of shares Rumsfeld owns, but in the past six months fears of a pandemic and the ensuing scramble for Tamiflu have sent Gilead's stock from $35 to $47. That's made the Pentagon chief, already one of the wealthiest members of the Bush cabinet, at least $1 million richer.

Rumsfeld isn't the only political heavyweight benefiting from demand for Tamiflu, which is manufactured and marketed by Swiss pharma giant Roche. (Gilead receives a royalty from Roche equaling about 10% of sales.) Former Secretary of State George Shultz, who is on Gilead's board, has sold more than $7 million worth of Gilead since the beginning of 2005.

Another board member is the wife of former California Gov. Pete Wilson.

"I don't know of any biotech company that's so politically well-connected," says analyst Andrew McDonald of Think Equity Partners in San Francisco.

What's more, the federal government is emerging as one of the world's biggest customers for Tamiflu. In July, the Pentagon ordered $58 million worth of the treatment for U.S. troops around the world, and Congress is considering a multi-billion dollar purchase. Roche expects 2005 sales for Tamiflu to be about $1 billion, compared with $258 million in 2004.

Rumsfeld recused himself from any decisions involving Gilead when he left Gilead and became Secretary of Defense in early 2001. And late last month, notes a senior Pentagon official, Rumsfeld went even further and had the Pentagon's general counsel issue additional instructions outlining what he could and could not be involved in if there were an avian flu pandemic and the Pentagon had to respond.
(ယုံၾကည္ခ်က္ ။ ။ မုဒိမ္းေကာင္ လူရမ္းကား ၀ါဒကုိ ေဒါသမထြက္ပါနဲ႔… ႏွိပ္ကြပ္ရလုိ႔လဲ ပီတိမျဖစ္ပါနဲ႔. . . ကုလားကုိလဲ လူမ်ဳိးေရး မႏွိပ္ကြပ္ပါနဲ႔ . . အဲဒါေတြက အက်ဳိးမရွိပါဘူး။ ယုတ္ညံ့သည့္ ၀ါဒဆုိးၾကီးကုိ ျဖဳိဖ်က္ေရးမွာ ခင္ဗ်ားကုိယ္တုိင္ အုတ္တစ္ခ်ပ္ သဲတစ္ပြင့္အျဖစ္ လုပ္ကုိင္ေရးက လက္ေတြ႔အက်ဆုံးျဖစ္ပါသည္ )

No comments: